Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

ZS Pharma, Inc. (ZSPH)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-14Dec-31-13Dec-31-12
   10-K10-K10-K
Revenues  0.00.00.0
Cost of goods sold  0.00.00.0
Gross profit  0.00.00.0
Selling, general and administrative   [+]14.97.41.1
Research and development  45.624.87.0
Other operating expenses  -3.1-1.4-0.1
EBITDA   [+]-56.1-30.1-8.0
Depreciation and amortization  1.30.70.0
EBIT   [+]-57.5-30.8-8.1
Non-recurring items  3.11.40.1
Interest expense, net   [+]0.40.02.1
Other income (expense), net  -3.1-1.4-0.1
Pre-tax income  -64.0-33.6-10.3
Income taxes  0.00.00.0
            Tax rate  0.0%0.0%0.0%
Net income  -64.0-33.6-10.3
   
Basic EPS   [+]($5.44)($21.41)($6.62)
Diluted EPS   [+]($5.44)($21.41)($6.62)
   
Shares outstanding (basic)   [+]11.81.61.6
Shares outstanding (diluted)   [+]11.81.61.6
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy